Search hospitals > North Carolina > Raleigh
Wake Research Associates
Claim this profileRaleigh, North Carolina 27612
Global Leader in Flu
Global Leader in Atopic Dermatitis
Conducts research for Crohn's Disease
Conducts research for Osteoarthritis
Conducts research for Coronavirus
323 reported clinical trials
7 medical researchers
Summary
Wake Research Associates is a medical facility located in Raleigh, North Carolina. This center is recognized for care of Flu, Atopic Dermatitis, Crohn's Disease, Osteoarthritis, Coronavirus and other specialties. Wake Research Associates is involved with conducting 323 clinical trials across 328 conditions. There are 7 research doctors associated with this hospital, such as Matthew Hong, Lisa Cohen, DO, Lisa Cohen Hong, and Pouru Bhiwandi, MD.Area of expertise
1Flu
Global Leaderestrogen
ER
2Atopic Dermatitis
Global LeaderTop PIs
Matthew HongGSK Investigational Site3 years of reported clinical research
Studies Respiratory Syncytial Virus Infection
Studies Respiratory Syncytial Virus
3 reported clinical trials
9 drugs studied
Lisa Cohen, DOM3 Wake Research Inc.2 years of reported clinical research
Studies Chikungunya
Studies Acid Reflux
3 reported clinical trials
4 drugs studied
Lisa Cohen HongM3 Wake Research Inc2 years of reported clinical research
Studies Coronavirus
1 reported clinical trial
3 drugs studied
Pouru Bhiwandi, MDM3 Wake Research, Inc3 years of reported clinical research
Studies Birth Control
1 reported clinical trial
1 drug studied
Clinical Trials running at Wake Research Associates
Crohn's Disease
Fatty Liver Disease
Celiac Disease
Obesity
Liver Fibrosis
Inflammatory Bowel Disease
Type 2 Diabetes
Ulcerative Colitis
Colitis
Birth Control
Vedolizumab + Adalimumab/Ustekinumab
for Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual targeted treatment. The study is conducted in two parts. In Part A, participants will receive the dual targeted treatment (vedolizumab together with either adalimumab or ustekinumab). In part B, participants will receive vedolizumab only. Part B will include participants who responded to the treatment in Part A. Each participant will be followed up for at least 26 weeks after the last dose of treatment.
Recruiting3 awards Phase 410 criteria
MORF-057
for Crohn's Disease
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).
Recruiting0 awards Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Wake Research Associates?
Wake Research Associates is a medical facility located in Raleigh, North Carolina. This center is recognized for care of Flu, Atopic Dermatitis, Crohn's Disease, Osteoarthritis, Coronavirus and other specialties. Wake Research Associates is involved with conducting 323 clinical trials across 328 conditions. There are 7 research doctors associated with this hospital, such as Matthew Hong, Lisa Cohen, DO, Lisa Cohen Hong, and Pouru Bhiwandi, MD.
Where is Wake Research Associates located?
Wake Research Associates is located at 3100 Duraleigh Rd, Suite 304, Raleigh, NC 27612. From downtown Raleigh, take I-440 E to I-40 E, exit 289 for Wade Avenue, turn right onto Wade Avenue, then left onto Duraleigh Road. The destination is on your right after about 0.5 miles.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Wake Research Associates, contact their department at 919-350-8359. They offer aid to those who don't qualify for Medicaid or other government programs, provided eligibility criteria are met and necessary documents are submitted within 240 days. For insurance inquiries, contact WakeMed's billing and insurance department at 919-350-7808, affiliated with Wake Research Associates, for information on insurance coverage and billing.
What insurance does Wake Research Associates accept?
Wake Research Associates is a clinical research organization focused on conducting clinical trials and advancing medical science through collaborations with healthcare providers, pharmaceutical companies, and research institutions. It does not function as a hospital or medical facility and does not provide direct patient care or accept insurance plans for medical treatments or procedures.
What awards or recognition has Wake Research Associates received?
Wake Research Associates, located in Raleigh, North Carolina, is renowned for its clinical research contributions. It has been honored as one of America's Greatest Workplaces for Diversity in 2023 by Newsweek and included in the Lown Institute's 2023 list of the nation's most socially responsible hospitals. The organization holds the American College of Cardiology's Chest Pain Center accreditation and the Society for Enhanced Recovery After Cardiac Surgery's accreditation, highlighting its excellence in cardiac care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.